Nicholas Dominic Cortezi Sells 29,466 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) Stock

Ryan Specialty Holdings, Inc. (NYSE:RYANGet Free Report) Director Nicholas Dominic Cortezi sold 29,466 shares of the stock in a transaction on Monday, January 13th. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96. Following the completion of the transaction, the director now owns 45,409 shares in the company, valued at approximately $2,954,309.54. This represents a 39.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Nicholas Dominic Cortezi also recently made the following trade(s):

  • On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.99, for a total transaction of $2,309,650.00.
  • On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The shares were sold at an average price of $65.00, for a total value of $5,915.00.
  • On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.17, for a total transaction of $2,280,950.00.
  • On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total transaction of $2,334,850.00.
  • On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00.

Ryan Specialty Trading Down 0.5 %

Shares of RYAN stock opened at $66.57 on Friday. Ryan Specialty Holdings, Inc. has a 1 year low of $42.21 and a 1 year high of $75.97. The company’s fifty day simple moving average is $67.95 and its two-hundred day simple moving average is $65.87. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market capitalization of $17.43 billion, a price-to-earnings ratio of 86.46, a PEG ratio of 1.12 and a beta of 0.72.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same quarter in the previous year, the firm earned $0.32 EPS. The company’s quarterly revenue was up 20.5% compared to the same quarter last year. As a group, analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were issued a $0.11 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.66%. Ryan Specialty’s payout ratio is currently 57.14%.

Analysts Set New Price Targets

RYAN has been the subject of several recent analyst reports. Morgan Stanley began coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price for the company. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their target price for the company from $65.00 to $75.00 in a research report on Tuesday, September 24th. Keefe, Bruyette & Woods cut their price target on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Friday, January 10th. Barclays raised their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. Finally, The Goldman Sachs Group boosted their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $74.40.

View Our Latest Research Report on Ryan Specialty

Institutional Investors Weigh In On Ryan Specialty

Several large investors have recently added to or reduced their stakes in the business. Hollencrest Capital Management purchased a new stake in shares of Ryan Specialty in the 3rd quarter valued at about $25,000. Assetmark Inc. bought a new position in shares of Ryan Specialty in the third quarter worth approximately $34,000. Quarry LP raised its stake in Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after purchasing an additional 422 shares in the last quarter. GAMMA Investing LLC lifted its position in Ryan Specialty by 106.4% during the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock valued at $83,000 after purchasing an additional 644 shares during the last quarter. Finally, Signaturefd LLC grew its stake in Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after buying an additional 148 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

About Ryan Specialty

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Insider Buying and Selling by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.